Ruiyi Ren

Dr. Ruiyi Ren

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
RRRuiyi Ren
Ruiyi Ren
GLGuorong Li
Guorong Li
TLThuy Duong Le
Thuy Duong Le
CKCasey Kopczynski
Casey Kopczynski
WSW. Daniel Stamer
W. Daniel Stamer
HGHaiyan Gong
Haiyan Gong
Purpose: Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in phase 3 clinical development for glaucoma treatment. We investigated the effects of its active metabolite, netarsudil-M1, on outflow facility (C), outflow hydrodynamics, and morphology of the conventional outflow pathway in enucleated human eyes. Methods: Paired human eyes (n = 5) were perfused with either 0.3 μM netarsudil-M1 or vehicle solution at constant pressure (15 mm Hg). After 3 hours, fluorescent microspheres were added to perfusion media to trace the outflow patterns before perfusion-fixation. The percentage effective filtration length (PEFL) was calculated from the measured lengths of tracer distribution in the trabecular meshwork (TM), episcleral veins (ESVs), and along the inner wall (IW) of Schlemm's canal after global and confocal imaging. Morphologic changes along the trabecular outflow pathway were investigated by confocal, light, and electron microscopy. Results: Perfusion with netarsudil-M1 significantly increased C when compared to baseline (51%, P < 0.01) and to paired controls (102%, P < 0.01), as well as significantly increased PEFL in both IW (P < 0.05) and ESVs (P < 0.01). In treated eyes, PEFL was significantly higher in ESVs than in the IW (P < 0.01) and was associated with increased cross-sectional area of ESVs (P < 0.01). Percentage effective filtration length in ESVs positively correlated with the percentage change in C (R2 = 0.58, P = 0.01). A significant increase in juxtacanalicular connective tissue (JCT) thickness (P < 0.05) was found in treated eyes compared to controls. Conclusions: Netarsudil acutely increased C by expansion of the JCT and dilating the ESVs, which led to redistribution of aqueous outflow through a larger area of the IW and ESVs.

15 December 2011 in Blood
Verified
Journal Article
Closed access
JWJennifer Ellis Ward
Jennifer Ellis Ward
RRRuiyi Ren
Ruiyi Ren
GTGianluca Toraldo
Gianluca Toraldo
PSPam SooHoo
Pam SooHoo
JGJian Guan
Jian Guan
DSDavid C. Seldin
David C. Seldin
Systemic AL amyloidosis results from the aggregation of an amyloidogenic immunoglobulin (Ig) light chain (LC) usually produced by a plasma cell clone in the bone marrow. AL is the most rapidly fatal of the systemic amyloidoses, as amyloid fibrils can rapidly accumulate in tissues including the heart, kidneys, autonomic or peripheral nervous systems, gastrointestinal tract, and liver. Chemotherapy is used to eradicate the cellular source of the amyloidogenic precursor. Currently, there are no therapies that target the process of LC aggregation, fibril formation, or organ damage. We developed transgenic mice expressing an amyloidogenic λ6 LC using the cytomegalovirus (CMV) promoter to circumvent the disruption of B cell development by premature expression of recombined LC. The CMV-λ6 transgenic mice develop neurologic dysfunction and Congophilic amyloid deposits in the stomach. Amyloid deposition was inhibited in vivo by the antibiotic doxycycline. In vitro studies demonstrated that doxycycline directly disrupted the formation of recombinant LC fibrils. Furthermore, treatment of ex vivo LC amyloid fibrils with doxycycline reduced the number of intact fibrils and led to the formation of large disordered aggregates. The CMV-λ6 transgenic model replicates the process of AL amyloidosis and is useful for testing the antifibril potential of orally available agents.

1 August 2013 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
CYChen-Yuan Charlie Yang
Chen-Yuan Charlie Yang
YLYe Liu
Ye Liu
ZLZhaozeng Lu
Zhaozeng Lu
RRRuiyi Ren
Ruiyi Ren
HGHaiyan Gong
Haiyan Gong
Purpose. To determine the effect of Y27632, a Rho-kinase inhibitor on aqueous outflow facility, flow pattern, and juxtacanalicular tissue (JCT)/trabecular meshwork (TM) morphology in human eyes. Methods. Sixteen enucleated human eyes were perfused with PBS plus glucose (GPBS) at 15 mm Hg to establish the baseline outflow facility. Six eyes were perfused for short-duration (30 minute) with either 50 μM Y27632 or GPBS (n = 3 per group). Ten eyes were perfused for long duration (3 hours) with either 50 μM Y27632 or GPBS (n = 5 per group). Outflow pattern was labeled using fluorescent microspheres, and effective filtration length (EFL) was measured. Morphologic changes and their relationship to EFL and facility were analyzed. Results. Outflow facility significantly increased after short-duration perfusion with Y27632 compared with its own baseline (P = 0.03), but did not reach statistical significance compared with its controls (P = 0.07). Outflow facility (P = 0.01) and EFL (P < 0.05) were significantly increased after long-duration perfusion with Y27632 compared with its controls. Increases in outflow facility and EFL demonstrated a positive correlation. Morphologically, the TM and JCT of high-tracer regions were more expanded compared with low-tracer regions. A significant increase in JCT thickness was found in the long-duration Y27632 group compared with its control group (10.0 vs. 8.0 μm, P < 0.01). Conclusions. Y27632 increases outflow facility in human eyes. This increase correlates positively with an increase in EFL, which is associated with an increased expansion in the JCT. Our data suggest that EFL could serve as a novel parameter to correlate with outflow facility.

15 July 2008 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
RRRuiyi Ren
Ruiyi Ren
AHA.E.K. Hutcheon
A.E.K. Hutcheon
XGX.Q. Guo
X.Q. Guo
NSN. Saeidi
N. Saeidi
SMS.A. Melotti
S.A. Melotti
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall
Our goal was to develop a 3‐D multi‐cellular construct using primary human corneal fibroblasts cultured on a disorganized collagen substrate in a scaffold‐free environment and to use it to determine the regulation of proteoglycans over an extended period of time (11 weeks). Electron micrographs revealed multi‐layered constructs with cells present in between alternating parallel and perpendicular arrays of fibrils. Type I collagen increased 2–4‐fold. Stromal proteoglycans including lumican, syndecan4, decorin, biglycan, mimecan, and perlecan were expressed. The presence of glycosaminoglycan chains was demonstrated for a subset of the core proteins (lumican, biglycan, and decorin) using lyase digestion. Cuprolinic blue–stained cultures showed that sulfated proteoglycans were present throughout the construct and most prominent in its mid‐region. The size of the Cuprolinic‐positive filaments resembled those previously reported in a human corneal stroma. Under the current culture conditions, the cells mimic a development or nonfibrotic repair phenotype. Developmental Dynamics 237:2705–2715, 2008.

1 October 2008 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
CMCourtney Mayo
Courtney Mayo
RRRuiyi Ren
Ruiyi Ren
CRCeleste Rich
Celeste Rich
Mary Ann SteppMary Ann Stepp
Mary Ann Stepp
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall
Purpose. Previously, the authors demonstrated that BzATP, a P2X7 receptor agonist, enhanced corneal epithelial migration in vitro. The goal here was to characterize the role of the P2X7 receptor in the repair of in vivo corneal epithelial debridement wounds and in the structural organization of the corneal stroma. methods. Epithelial debridement was performed on P2X7 knockout (P2X7 −/−) and wild-type (WT) mice, and eyes were harvested after 16 hours. Corneas were stained with Richardson vital stain, and the wound area was recorded. Corneas were fixed and prepared for light microscopic, immunohistochemical, and electron microscopic analysis. Cuprolinic blue staining was performed to analyze stromal proteoglycans (PGs). Real-time PCR was performed to examine the expression of stromal collagens. results. P2X7 was present in the WT corneal epithelium but was not detected in P2X7 −/− mice. Pannexin-1, a protein demonstrated to interact with P2X7, was absent from the wound edge in P2X7 −/−. This was associated with a trend toward delayed corneal reepithelialization. Stromal ultrastructure and collagen alignment were altered in P2X7 −/−, and collagen fibrils had smaller diameters with a larger interfibrillar distances. Expression of collagen alpha1(I) and alpha3(v) was reduced. There were 30% fewer sulfated PGs along fibrils in the P2X7 −/− stroma. conclusions. In the absence of the P2X7 receptor, the expression of proteins in the corneal epithelium was altered and wound healing was compromised. Loss of receptor resulted in morphologic changes in the stroma, including changes in alignment of collagen fibrils, decreased expression of collagen, and smaller fibrils with fewer PGs per fibril.

1 December 2006 in The American Journal of Pathology
Verified
Journal Article
Closed access
GMGrace Fortes Monis
Grace Fortes Monis
CSChristopher Schultz
Christopher Schultz
RRRuiyi Ren
Ruiyi Ren
JEJeremy Eberhard
Jeremy Eberhard
CCCatherine E Costello
Catherine E Costello
VTVickery Trinkaus-Randall
Vickery Trinkaus-Randall